Experience of using immunocorringing therapy for HIV infection
This paper describes the complex use of antiretroviral therapy and the unique immunocorrector IMMUN-5. The results presented in the table show that during 6 months of complex therapy, the viral load in all patients in the experimental groups fell by hundreds and thousands of times, and the number of CD4 cells grew. The authors suggest that it is possible to achieve longterm remission in all patients. This will eliminate a link in the epidemic chain as a source of infection, and this will create guidelines for the development of effective global programs to combat the AIDS epidemic.